ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 186 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $27,000 | +22.7% | 2,000 | -33.3% | 0.01% | +22.2% |
| Q2 2016 | $22,000 | +15.8% | 3,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $19,000 | 0.0% | 3,000 | 0.0% | 0.01% | +28.6% |
| Q4 2015 | $19,000 | +11.8% | 3,000 | 0.0% | 0.01% | +16.7% |
| Q3 2015 | $17,000 | -32.0% | 3,000 | 0.0% | 0.01% | -33.3% |
| Q2 2015 | $25,000 | 0.0% | 3,000 | 0.0% | 0.01% | +12.5% |
| Q1 2015 | $25,000 | +4.2% | 3,000 | -14.3% | 0.01% | -11.1% |
| Q4 2014 | $24,000 | -20.0% | 3,500 | -36.4% | 0.01% | -25.0% |
| Q3 2014 | $30,000 | +57.9% | 5,500 | +83.3% | 0.01% | +50.0% |
| Q2 2014 | $19,000 | -20.8% | 3,000 | 0.0% | 0.01% | -20.0% |
| Q1 2014 | $24,000 | +20.0% | 3,000 | 0.0% | 0.01% | +11.1% |
| Q4 2013 | $20,000 | -63.6% | 3,000 | 0.0% | 0.01% | -73.5% |
| Q3 2013 | $55,000 | +3.8% | 3,000 | 0.0% | 0.03% | -2.9% |
| Q2 2013 | $53,000 | – | 3,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
| Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
| Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
| Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
| Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
| Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
| 1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
| Geduld E E | 120,100 | $767,000 | 1.05% |
| JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |